As of 2026-01-02, the Relative Valuation of Dexcom Inc (DXCM) is 64.23 USD. This relative valuation is based on P/E multiples. With the latest stock price at 66.37 USD, the upside of Dexcom Inc based on Relative Valuation is -3.2%.
The range of the Relative Valuation is 60.05 - 70.74 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.0x - 38.3x | 36.2x |
| Forward P/E multiples | 31.6x - 33.8x | 32.4x |
| Fair Price | 60.05 - 70.74 | 64.23 |
| Upside | -9.5% - 6.6% | -3.2% |
| Date | P/E |
| 2025-12-31 | 35.92 |
| 2025-12-30 | 36.29 |
| 2025-12-29 | 36.51 |
| 2025-12-26 | 36.57 |
| 2025-12-24 | 36.49 |
| 2025-12-23 | 36.18 |
| 2025-12-22 | 36.49 |
| 2025-12-19 | 35.75 |
| 2025-12-18 | 35.67 |
| 2025-12-17 | 35.58 |
| 2025-12-16 | 35.92 |
| 2025-12-15 | 35.57 |
| 2025-12-12 | 36.24 |
| 2025-12-11 | 37.31 |
| 2025-12-10 | 36.56 |
| 2025-12-09 | 35.90 |
| 2025-12-08 | 35.51 |
| 2025-12-05 | 35.44 |
| 2025-12-04 | 35.31 |
| 2025-12-03 | 35.09 |
| 2025-12-02 | 34.88 |
| 2025-12-01 | 34.38 |
| 2025-11-28 | 34.35 |
| 2025-11-26 | 33.84 |
| 2025-11-25 | 33.38 |
| 2025-11-24 | 33.67 |
| 2025-11-21 | 32.59 |
| 2025-11-20 | 31.62 |
| 2025-11-19 | 32.32 |
| 2025-11-18 | 32.56 |
| 2025-11-17 | 31.65 |
| 2025-11-14 | 31.42 |
| 2025-11-13 | 32.32 |
| 2025-11-12 | 32.26 |
| 2025-11-11 | 31.46 |
| 2025-11-10 | 29.68 |
| 2025-11-07 | 29.76 |
| 2025-11-06 | 31.40 |
| 2025-11-05 | 32.08 |
| 2025-11-04 | 33.11 |
| 2025-11-03 | 32.70 |
| 2025-10-31 | 31.51 |
| 2025-10-30 | 36.91 |
| 2025-10-29 | 36.90 |
| 2025-10-28 | 37.47 |
| 2025-10-27 | 38.22 |
| 2025-10-24 | 38.06 |
| 2025-10-23 | 38.46 |
| 2025-10-22 | 38.26 |
| 2025-10-21 | 37.75 |